[go: up one dir, main page]

Mastelic et al., 2012 - Google Patents

Environmental and T cell–intrinsic factors limit the expansion of neonatal follicular T helper cells but May Be circumvented by specific adjuvants

Mastelic et al., 2012

Document ID
11127921635879157820
Author
Mastelic B
Kamath A
Fontannaz P
Tougne C
Rochat A
Belnoue E
Combescure C
Auderset F
Lambert P
Tacchini-Cottier F
Siegrist C
Publication year
Publication venue
The Journal of Immunology

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Mastelic et al. Environmental and T cell–intrinsic factors limit the expansion of neonatal follicular T helper cells but May Be circumvented by specific adjuvants
Elsner et al. Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity
Codarri Deak et al. PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells
Prokhnevska et al. CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Zander et al. Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection
US11905529B2 (en) Method of enhancing persistence of adoptively infused T cells
Maue et al. T-cell immunosenescence: lessons learned from mouse models of aging
Linterman et al. CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection
Gracias et al. The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling
Curran et al. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
Peperzak et al. CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production
Lind et al. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges
JP6175103B2 (en) Methods for increasing immune response
Han et al. Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-γ
Lapteva et al. Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation
Jash et al. ZBTB32 restricts the duration of memory B cell recall responses
Maue et al. Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells
Tanaka et al. Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus
Scholz et al. Vitamin A controls the allergic response through T follicular helper cell as well as plasmablast differentiation
Sun et al. NLRC5 deficiency has a moderate impact on immunodominant CD 8+ T‐cell responses during rotavirus infection of adult mice
Yee Mon et al. Functionalized nanowires for miRNA-mediated therapeutic programming of naïve T cells
Zheng et al. Generation of human Th1‐like regulatory CD4+ T cells by an intrinsic IFN‐γ‐and T‐bet‐dependent pathway
Amani et al. Intracellular galectin-3 is essential for OX40-mediated memory CD8+ T cell development
Lemaitre et al. Loss of the transfer RNA wobble uridine–modifying enzyme Elp3 delays T cell cycle entry and impairs T follicular helper cell responses through deregulation of Atf4
Martin et al. CD40 signaling in CD8+ CD40+ T cells turns on contra-T regulatory cell functions